Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Do Hedge Funds Love AEterna Zentaris Inc. (USA) (AEZS)?

With a general bullishness amongst the heavyweights, specific money managers have jumped into AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) headfirst. Ken Griffin’s Citadel Investment Group initiated a $0.1 million position during the quarter. The only other fund with a brand new AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) position is Two Sigma Advisors.

Let’s also examine hedge fund activity in other stocks – not necessarily in the same industry as AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) but similarly valued. We will take a look at EnteroMedics Inc (NASDAQ:ETRM), Biodel Inc (NASDAQ:BIOD), Rubicon Technology, Inc. (NASDAQ:RBCN), and Echelon Corporation (NASDAQ:ELON). This group of stocks’ market caps is closest to AEterna Zentaris Inc. (USA) (NASDAQ:AEZS)’s market cap.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
ETRM 5 809 -1
BIOD 8 6239 -1
RBCN 5 8457 -2
ELON 4 3549 -1

As you can see, these stocks had an average of 6 hedge funds with bullish positions and the average amount invested in these stocks was $5 million. That figure was $1 million in AEZS’s case. Biodel Inc (NASDAQ:BIOD) is on top of the popularity list with 8 hedge fund holdings, whereas Echelon Corporation (NASDAQ:ELON) is the least popular one with only 4 bullish hedge fund positions. AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) shares the same investor sentiment as that of Echelon Corporation (NASDAQ:ELON), with both having four hedge fund investors each. Considering that hedge funds aren’t fond of this stock in relation to other companies compared in this article, it may be a good idea to analyze it in detail and understand why the smart money isn’t behind this stock. This isn’t necessarily bad news. Although it is possible that hedge funds may think the stock is overpriced and view the stock as a short candidate, they may not be very familiar with the bullish thesis. In either case, more research is warranted.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.